112
M.P. Sathisha et al. / European Journal of Medicinal Chemistry 45 (2010) 106–113
Table 4
Effect of drugs on body weight changes in tumor induced mice.
Group
Dose (mg/Kg) i.p.
% increase in weight as compared to day-0 (mean ꢂ SE)
Day-3
Day-6
Day-9
Day-12
Day-15
Control
Cisplatin
LH
[CoLCl]$2H2O
[NiLCl$2H2O]
[CuLCl]
–
3.96 ꢂ 1.77
3.81 ꢂ 1.55
4.45 ꢂ 1.62
3.81 ꢂ 1.21
4.21 ꢂ 1.34
4.62 ꢂ 1.48
4.34 ꢂ 1.45
6.84 ꢂ 1.69
13.04 ꢂ 1.22
13.29 ꢂ 1.27
11.34 ꢂ 1.33
12.34 ꢂ 2.56
17.54 ꢂ 2.23
16.43 ꢂ 1.58
16.43 ꢂ 1.45
18.27 ꢂ 1.22
19.08 ꢂ 3.41
19.46 ꢂ 3.61
18.49 ꢂ 3.51
21.32 ꢂ 1.72
18.32 ꢂ 1.53
18.15 ꢂ 1.59
8.72 ꢂ 2.22a
16.54 ꢂ 2.35
18.71 ꢂ 4.33
13.56 ꢂ 2.39
16.42 ꢂ 3.03
16.54 ꢂ 1.65
21.25 ꢂ 2.34
1.53 ꢂ 3.24a
7.43 ꢂ 2.45a
14.61 ꢂ 1.82
7.24 ꢂ 1.65a
7.55 ꢂ 3.23a
8.45 ꢂ 2.39a
3.5
50
50
50
50
50
[ZnLCl]
a
p < 0.05 Vs Control.
9.83 (9.79); S, 7.49 (7.45); Cu, 14.88 (14.83); Cl, 8.30 (8.27). FT-IR
(KBr) cmꢁ1: 3445 (s)
(OH), 3335 (s) (NH), 2978–2897 (m) (CH),
(C]S). Molar conductance:
5th, 7th, 10th, 12th, and 14th day of tumor inoculation in the
volume of 0.1 ml/10 g mice. All the compounds were tested at the
dose of 50 mg/kg body weight. The dose of cisplatin selected was
3.5 mg/kg. This was calculated by using body mass Index and past
experience with the drug [24].
n
n
n
1590 (vs)
d
(N–H), 1035 (s)
n
20 mho cm2molꢁ1. Magnetic moment: 1.93 BM.
5.2.4. [ZnLCl]
Yield w75%, Mp > 280 ꢃC. Elemental analysis: Calculated
(found) for [Zn(C13H18N3O5S) Cl].2H2O: C, 34.89 (34.82); H, 4.47
(4.45); N, 9.39 (9.33); S, 7.15 (7.12); Ni, 12.81 (12.78); Cl, 7.74 (7.71).
5.3.4. Determination of cytotoxicity of compounds against EAC cells
(In vitro studies, Tryphan Blue Exclusion Method (Cell Viability
Test))
FT-IR (KBr) cmꢁ1: 3368 (br s)
n
(OH), 2929 (m)
n(CH),1600 (vs) d(N–H),
In vitro short-term cytotoxic activity of drug was determined
using EAC cells. The EAC cells that were collected from the animal
peritoneum by aspiration were washed repeatedly with PBS to free
it from blood. After checking the viability of the cells in a haemo-
cytometer, a cell (1 ꢀ106) in 0.1 ml PBS, 0.01 ml of various
1033 (s)
n
(C]S). 1H NMR (DMSO)
d: 10.50 (s, 1H, hydrazide NH),
8.90–9.00 (2s,1H, glycosylic N–H), 7.12–7.60 (m, 5H, Ar), 4.99 (d,1H,
C–1–H), 4.60 (s, 1H, Ar–C–NH), 3.77–3.07 (m, –OH and –H of
saccharide moiety). Molar conductance: 24 mho cm2molꢁ1
.
concentrations of test compounds (1–50 mg/ml) were made (the
test compounds were dissolved in dimethylsulphoxide (DMSO), the
final concentration of DMSO not exceeding 0.1% of the total volume)
and phosphate buffered saline (0.1 mole/l, pH 7) in a total volume of
0.9 ml were incubated in clean sterile tubes for 3 h at 37 ꢃC. The
5.3. Antitumor activity
5.3.1. Cell lines
Cancer cell lines viz. Ehrlich’s Ascitic Carcinoma (EAC), to induce
cancer in animal model (mice) were obtained from Amala Cancer
Research Center, Amala Nagar, Thrissur, Kerala, India. The cells were
maintained as ascites tumor in Swiss albino mice by intraperitoneal
inoculation of 1 ꢀ106 viable cells.
control tube had 10
ml of solvent. The final volume was made up to
0.9 ml with PBS. To each 100
ml of Tryphan blue solution was added.
The live (without stain) and dead (with blue stain) cells were
counted using haemocytometer and percent cell death was calcu-
lated using the formula:
5.3.2. Animals
%Cytotoxicity [ 1003ðTdead L CdeadÞ=Ttot
Female Swiss albino mice of 6–8 weeks old (25 ꢂ 5 g body
weight) were selected. The animals were acclimatized to the
experimental room having temperature 23 ꢂ 2 ꢃC, controlled
humidity conditions, and 12:12 h light and dark cycle. The Mice
were housed in sterile polypropylene cages containing sterile
paddy husk as bedding material with maximum of 4 animals in
each cage. The mice were fed on autoclaved standard mice food
pellets (Hindustan Lever) and water ad libitum. The animal exper-
iments were performed according to the rules and regulations of
the Institutional Animal Ethics Committee (IAEC).
where, Tdead is the No. of dead cells in the treated group, Cdead is
that in the control group and Ttot is the total number of dead and
live cells in the test compound treated group. Cisplatin was used as
the standard [25].
5.3.5. Induction of Ehrlich Ascites Carcinoma [22]
Antitumor activities of compounds were determined using
Ehrlich Ascites Carcinoma (EAC) tumor model in mice. Female
Swiss albino mice were divided into groups of 6 animals each.
(A. Tumor bearing mice, B. Tumor bearing mice treated with one
dose of Cisplatin, C. Tumor bearing mice groups treated with
compounds). The ascites carcinoma-bearing mice (donor) were
used for the study, 15 days after tumor transplantation. The ascitic
fluid was drawn using an 18-gauge needle into sterile syringe.
A small amount was tested for microbial contamination. Tumor
viability was determined by Tryphan blue exclusion test and cells
were counted using haemocytometer. The ascitic fluid was suitably
diluted in normal saline to get a concentration of 106 cells/ml. of
tumor cell suspension. This was injected intraperitonealy to obtain
ascitic tumor. The mice were weighed on the day of tumor inocu-
lation and then once in three days thereafter. Treatment was star-
ted on the 3rd, 5th, 7th, 10th, 12th, and 14th day of tumor
inoculation. Cisplatin (one dose) was injected on 1st day intra-
peritonealy. The animals in each of the groups were kept to check
the mean survival time (MST) of the tumor bearing hosts.
5.3.3. Preparation of test solution of compounds
The solutions of the compounds were prepared by suspending
them in 2% acacia and administrated intraperitoneally on 3rd,
Table 5
Effect of drugs on the survival time in tumor induced mice.
Group
Dose (mg/kg) LC50 in M ꢀ 10ꢁ8 Mean survival time (days)
(Mean ꢂ SEM) %T/C
%ILS
Control
Cisplatin
LH
–
3.5
50
–
19.00 ꢂ 0.37
–
–
2.76
3.14
3.69
2.89
1.94
2.56
38.29 ꢂ 1.17a 201.53 101.53
27.83 ꢂ 0.48a 146.47 46.47
22.50 ꢂ 0.43a 118.42 18.42
25.83 ꢂ 0.43a 135.95 35.95
28.83 ꢂ 0.43a 151.74 51.74
27.67 ꢂ 0.42a 145.63 45.63
[CoLCl]$2H2O 50
[NiLCl$2H2O] 50
[CuLCl]
[ZnLCl]
50
50
a
p < 0.05 Vs Control Groups.